Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03161756
Title Evaluation of Denosumab in Combination With Immune Checkpoint Inhibitors in Patients With Unresectable or Metastatic Melanoma (CHARLI)
Acronym CHARLI
Recruitment Unknown status
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Melanoma and Skin Cancer Trials Limited
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS


No variant requirements are available.